News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
407,393 Results
Type
Article (15788)
Company Profile (117)
Press Release (391483)
Multimedia
Podcasts (50)
Webinars (9)
Section
Business (121750)
Career Advice (464)
Deals (20819)
Drug Delivery (41)
Drug Development (35767)
Employer Resources (51)
FDA (9773)
Job Trends (8043)
News (190687)
Policy (14549)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1361)
Accelerated approval (11)
Allergies (74)
Alliances (37885)
ALS (48)
Alzheimer's disease (717)
Antibody-drug conjugate (ADC) (194)
Approvals (10042)
Artificial intelligence (448)
Autoimmune disease (71)
Automation (31)
Bankruptcy (136)
Best Places to Work (6706)
BIOSECURE Act (7)
Biosimilars (85)
Biotechnology (91)
Bladder cancer (70)
Brain cancer (28)
Breast cancer (276)
Cancer (2400)
Cardiovascular disease (156)
Career advice (423)
Career pathing (9)
CAR-T (206)
CDC (8)
Cell therapy (508)
Cervical cancer (21)
Clinical research (30112)
Collaboration (1316)
Compensation (241)
Complete response letters (11)
COVID-19 (1276)
CRISPR (85)
C-suite (519)
Cystic fibrosis (65)
Data (2950)
Decentralized trials (1)
Denatured (26)
Depression (47)
Diabetes (220)
Diagnostics (5253)
Digital health (37)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (179)
Drug pricing (20)
Drug shortages (4)
Duchenne muscular dystrophy (94)
Earnings (44443)
Editorial (9)
Employer branding (8)
Employer resources (46)
Events (56962)
Executive appointments (576)
FDA (11575)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (941)
Gene editing (171)
Generative AI (39)
Gene therapy (354)
GLP-1 (328)
Government (1396)
Grass and pollen (3)
Guidances (240)
Healthcare (10284)
HIV (24)
Huntington's disease (13)
IgA nephropathy (36)
Immunology and inflammation (72)
Immuno-oncology (22)
Indications (55)
Infectious disease (1425)
Inflammatory bowel disease (95)
Inflation Reduction Act (6)
Influenza (77)
Intellectual property (160)
Interviews (52)
IPO (8731)
IRA (10)
Job creations (1604)
Job search strategy (370)
JPM (22)
Kidney cancer (6)
Labor market (24)
Layoffs (137)
Leadership (7)
Legal (3194)
Liver cancer (48)
Longevity (6)
Lung cancer (304)
Lymphoma (186)
Machine learning (34)
Management (18)
Manufacturing (545)
MASH (39)
Medical device (11993)
Medtech (12042)
Mergers & acquisitions (12794)
Metabolic disorders (432)
Multiple sclerosis (67)
NASH (3)
Neurodegenerative disease (134)
Neuropsychiatric disorders (20)
Neuroscience (1209)
NextGen: Class of 2026 (3609)
Non-profit (1560)
Now hiring (15)
Obesity (157)
Opinion (98)
Ovarian cancer (102)
Pain (111)
Pancreatic cancer (103)
Parkinson's disease (128)
Partnered (22)
Patents (320)
Patient recruitment (267)
Peanut (31)
People (35701)
Pharmaceutical (20)
Pharmacy benefit managers (6)
Phase 1 (10536)
Phase 2 (13316)
Phase 3 (9213)
Pipeline (2851)
Policy (59)
Postmarket research (682)
Preclinical (4600)
Press Release (66)
Prostate cancer (111)
Psychedelics (6)
Radiopharmaceuticals (184)
Rare diseases (335)
Real estate (3689)
Recruiting (23)
Regulatory (11999)
Reports (20)
Research institute (1337)
Resumes & cover letters (69)
Rett syndrome (21)
RNA editing (10)
RSV (41)
Schizophrenia (35)
Series A (168)
Series B (120)
Service/supplier (6)
Sickle cell disease (35)
Special edition (1)
Spinal muscular atrophy (64)
Sponsored (20)
Startups (2648)
State (2)
Stomach cancer (2)
Supply chain (52)
Tariffs (10)
The Weekly (23)
Vaccines (505)
Venture capital (43)
Weight loss (54)
Women's health (49)
Worklife (2)
Date
Today (79)
Last 7 days (329)
Last 30 days (1190)
Last 365 days (15939)
2026 (1638)
2025 (16230)
2024 (19937)
2023 (23455)
2022 (32666)
2021 (34451)
2020 (32788)
2019 (27313)
2018 (20655)
2017 (20337)
2016 (19088)
2015 (22301)
2014 (16731)
2013 (14135)
2012 (15237)
2011 (15581)
2010 (14220)
Location
Africa (364)
Alabama (69)
Alaska (6)
Arizona (181)
Arkansas (10)
Asia (34629)
Australia (5175)
California (5597)
Canada (1828)
China (736)
Colorado (287)
Connecticut (249)
Delaware (111)
Europe (56479)
Florida (936)
Georgia (220)
Hawaii (2)
Idaho (33)
Illinois (485)
India (50)
Indiana (276)
Iowa (8)
Japan (355)
Kansas (101)
Kentucky (15)
Louisiana (18)
Maine (25)
Maryland (747)
Massachusetts (3810)
Michigan (279)
Minnesota (419)
Mississippi (4)
Missouri (99)
Montana (27)
Nebraska (16)
Nevada (52)
New Hampshire (83)
New Jersey (1750)
New Mexico (18)
New York (1509)
North Carolina (802)
North Dakota (9)
Northern California (2377)
Ohio (170)
Oklahoma (16)
Oregon (24)
Pennsylvania (1080)
Puerto Rico (19)
Rhode Island (34)
South America (569)
South Carolina (60)
South Dakota (1)
Southern California (2410)
Tennessee (104)
Texas (896)
United States (20871)
Utah (197)
Vermont (1)
Virginia (118)
Washington D.C. (19)
Washington State (525)
West Virginia (3)
Wisconsin (90)
Wyoming (1)
407,393 Results for "covalon technologies ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome
April 3, 2025
·
3 min read
Press Releases
Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON
September 25, 2025
·
6 min read
Business
Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO
Covalon Technologies Ltd. today announced that its Board of Directors (the “ Board ”) has appointed Mr. Brent Ashton to serve as Chief Executive Officer and a director of the Company, effective immediately.
January 4, 2024
·
6 min read
Business
Covalon Announces Profitable Second Quarter Fiscal 2024 Results
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 second quarter results for the period ended March 31, 2024.
May 29, 2024
·
15 min read
Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Infusion Nurses Society Annual Meeting and Exhibition, to be held in Kansas City, Missouri from Saturday, May 18 to Monday, May 20, 2024.
May 17, 2024
·
5 min read
Business
Covalon Announces Management Changes
Covalon Technologies Ltd. today announced the following management changes.
January 26, 2024
·
3 min read
Press Releases
Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel
November 14, 2025
·
4 min read
Press Releases
Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)
September 16, 2025
·
5 min read
Business
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results
Covalon Technologies Ltd., an advanced medical technologies company, will release its Q2 Fiscal 2024 financial results on Wednesday, May 29, 2024, before markets open.
May 22, 2024
·
3 min read
Press Releases
Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares
December 2, 2025
·
4 min read
1 of 40,740
Next
